A novel Chimeric Antigen Receptor (CAR) - strategy to target EGFRVIII-mutated glioblastoma cells via macrophages
Abstract Background Autologous chimeric antigen receptor (CAR) expressing T-Cells (CAR-T) have been efficiently used in hematological malignancies but their efficacy in solid tumors remains limited. CAR therapies via the use of macrophages, offer a promising avenue due to their unique ability to inf...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2026-05-01
|
| Reeks: | BMC Cancer |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s12885-026-16080-5 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
